Hepato-Protection Effect of Curcumin Against Methylphenidate-Induced Hepatotoxicity: Histological and Biochemical Evidences

Overview

Journal Int J Prev Med

Date 2022 Jun 16

PMID 35706867

Authors

Haleh Ahmadinasab

Majid Motaghinejad

Bahareh Arabzadeh Nosratabad

Seyedehnahal Bozorgniahosseini

Parastoo Rostami

Golbarg Shabani Jafarabadi

Manijeh Motevalian

Affiliations

Soon will be listed here.

Abstract

Background: As a psychostimulant agent, methylphenidate (MPH) abuse can cause serious liver damage. Studies have documented the hepatoprotective impacts of curcumin on liver damage. According to this definition, the purpose of this study is to explain the hapatoprotective effects of curcumin against the hepatotoxicity induced by MPH.

Methods: Seventy rats were equally divided into seven groups (10 rats per group). Groups 1 and 2 received normal saline (0.7 mL/rat) and MPH (10 mg/kg), respectively for 21 days. Groups 3, 4, 5, and 6 concurrently received MPH (10 mg/ kg) and curcumin (10, 20, 40, and 60 mg/kg, respectively) for 21 days. Group 7 was treated with curcumin (60 mg/kg) alone for 21 days. The hepatic function test key enzymes such as AST, ALP, and histology of liver tissue (ALT), and alkaline phosphatase (ALP) levels was studied in the blood samples, and also, the histopathological changes and cell density changes were evaluated in the liver tissue.

Results: The latest studies have shown that the administration of MPH induces rises in the AST, ALT, and ALP levels and induces degeneration changes in histopathology, whereas curcumin administration at doses of 40 and 60 mg/kg reduced the elevation of MPH-induced hepatic enzyme and inhibited histopathological degeneration in the MPH-treated classes. Curcumin alone (60 mg/kg) did not alter the biochemical and histological parameters.

Conclusions: Curcumin can function as a hepatoprotective agent against MPH-induced hepatotoxicity.

References

Motaghinejad M, Bangash M, Hosseini P, Karimian S, Motaghinejad O . Attenuation of morphine withdrawal syndrome by various dosages of curcumin in comparison with clonidine in mouse: possible mechanism. Iran J Med Sci. 2015; 40(2):125-32. PMC: 4359932. View

Moran L, Ongur D, Hsu J, Castro V, Perlis R, Schneeweiss S . Psychosis with Methylphenidate or Amphetamine in Patients with ADHD. N Engl J Med. 2019; 380(12):1128-1138. PMC: 6543546. DOI: 10.1056/NEJMoa1813751. View

Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T . Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol. 2001; 96(11):3142-6. DOI: 10.1111/j.1572-0241.2001.05268.x. View

Alam N, Ikram R . Methylphenidate-induced hepatotoxicity in rats and its reduction by buspirone. Pak J Pharm Sci. 2018; 31(3):741-745. View

Motaghinejad M, Motevalian M . Involvement of AMPA/kainate and GABAA receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus. Eur J Pharmacol. 2016; 784:181-91. DOI: 10.1016/j.ejphar.2016.04.036. View

Sahay A, Hen R . Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007; 10(9):1110-5. DOI: 10.1038/nn1969. View

Motaghinejad M, Motevalian M, Shabab B . Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats. Neurosci Lett. 2015; 619:106-13. DOI: 10.1016/j.neulet.2015.12.015. View

Khokhar N . Serum aminotransferase levels and platelet count as predictive factor of fibrosis and cirrhosis in patients with chronic hepatitis C infection. J Pak Med Assoc. 2003; 53(3):101-4. View

Nixon K, Crews F . Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J Neurochem. 2002; 83(5):1087-93. DOI: 10.1046/j.1471-4159.2002.01214.x. View

10.

Lewis J, Iezzoni J, Berg C . Methylphenidate-induced autoimmune hepatitis. Dig Dis Sci. 2007; 52(2):594-7. DOI: 10.1007/s10620-006-9525-2. View

11.

Giannini E, Testa R, Savarino V . Liver enzyme alteration: a guide for clinicians. CMAJ. 2005; 172(3):367-79. PMC: 545762. DOI: 10.1503/cmaj.1040752. View

12.

Somanawat K, Thong-Ngam D, Klaikeaw N . Curcumin attenuated paracetamol overdose induced hepatitis. World J Gastroenterol. 2013; 19(12):1962-7. PMC: 3613112. DOI: 10.3748/wjg.v19.i12.1962. View

13.

Vera-Ramirez L, Perez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles J . Curcumin and liver disease. Biofactors. 2013; 39(1):88-100. DOI: 10.1002/biof.1057. View

14.

Shellenberg T, Stoops W, Lile J, Rush C . An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. Expert Rev Clin Pharmacol. 2020; 13(8):825-833. DOI: 10.1080/17512433.2020.1796636. View

15.

Motaghinejad M, Karimian M, Motaghinejad O, Shabab B, Yazdani I, Fatima S . Protective effects of various dosage of Curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus. Pharmacol Rep. 2015; 67(2):230-5. DOI: 10.1016/j.pharep.2014.09.006. View

16.

Naik S, Thakare V, Patil S . Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property. Exp Toxicol Pathol. 2010; 63(5):419-31. DOI: 10.1016/j.etp.2010.03.001. View

17.

Mohanty I, Arya D, Dinda A, Joshi S, Talwar K, Gupta S . Protective effects of Curcuma longa on ischemia-reperfusion induced myocardial injuries and their mechanisms. Life Sci. 2004; 75(14):1701-11. DOI: 10.1016/j.lfs.2004.02.032. View

18.

Thiyagarajan M, Sharma S . Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2003; 74(8):969-85. DOI: 10.1016/j.lfs.2003.06.042. View

19.

Raoofi A, Delbari A, Mahdian D, Mojadadi M, Amini A, Javadinia S . Toxicology of long-term and high-dose administration of methylphenidate on the kidney tissue - a histopathology and molecular study. Toxicol Mech Methods. 2020; 30(8):611-619. DOI: 10.1080/15376516.2020.1805665. View

20.

Fekete S, Romanos M, Gerlach M . [Does methylphenidate cause liver damage? An analysis of ad hoc reports to the "Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)"]. Z Kinder Jugendpsychiatr Psychother. 2017; 46(4):342-348. DOI: 10.1024/1422-4917/a000565. View